Description

D-Myo-Inositol, 2,4-Bis-o-(Phenylmethyl)-5-o-2-Propenyl-1,6-o-(1R,2R,4R)-1,7,7-Trimethylbicyclo2.2.1Hept-2-Ylidene- is a sophisticated, high-purity chiral intermediate derived from myo-inositol, featuring a complex bicyclic protecting group. This compound matters for its role as a critical building block in the stereoselective synthesis of complex bioactive molecules, particularly in pharmaceutical research. It is primarily needed by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries for developing new therapeutic agents and advanced materials.

Application

• Pharmaceutical Intermediate: A key chiral precursor in the synthesis of novel drug candidates, particularly for targeting metabolic and neurological pathways.
• Asymmetric Synthesis: Used in the construction of complex natural products and bioactive compounds requiring high stereochemical purity.
• Glycobiology Research: Serves as a protected inositol derivative for studying inositol phosphate signaling pathways and glycosylation processes.
• Agrochemical Development: Employed in the research and development of new, more selective pesticides and herbicides.
• Chemical Biology Probes: Utilized to create labeled or modified inositol derivatives for probing enzyme mechanisms and cellular processes.
• Process Chemistry: Acts as a standardized intermediate for scaling up the production of target molecules under Current Good Manufacturing Practice (cGMP) conditions.

Basic Information

Product Name	D-Myo-Inositol, 2,4-Bis-o-(Phenylmethyl)-5-o-2-Propenyl-1,6-o-(1R,2R,4R)-1,7,7-Trimethylbicyclo2.2.1Hept-2-Ylidene-
CAS No.	196302-94-0
Molecular Formula	C33H42O6
Molecular Weight	534.69 g/mol
Synonyms	1,6-O-(1,7,7-Trimethyl-2-norbornylidene)-2,4-di-O-benzyl-5-O-allyl-myo-inositol; 2,4-Di-O-benzyl-5-O-allyl-1,6-O-[(1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene]-myo-inositol; D-myo-Inositol, 2,4-bis-O-(phenylmethyl)-5-O-2-propenyl-1,6-O-[(1R,2R,4R)-1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene]-; Protected D-myo-Inositol derivative; Chiral inositol intermediate; (-)-DCIB (common abbreviation for related structures); Contact for additional synonyms.
EINECS	Contact for details

Quality Control

Our D-Myo-Inositol derivative is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, chiral analysis, and NMR for structural confirmation, to ensure it meets the exacting standards required for advanced synthetic applications. Certificates of Analysis (COA) with full analytical data are provided for every shipment. We support development under research and cGMP guidelines as required.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The product is sensitive to strong acids and organic solvents; keep away from incompatible materials. For long-term storage under inert atmosphere, please contact our technical team for specific recommendations.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Chiral Purity	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.